Curcumin nano-formulation: enhanced anti-cancer and anti-microbial properties
Summary
The project aims to design and develop curcumin nanoparticles using various fabrication approaches, including liposome-nanoparticle assemblies and polymer-coated nanoparticles. The in vitro anti-cancer and anti-microbial activities of such curcumin nanoparticles will be assessed. The project will develop curcumin nanoparticles that target cancer cells by immobilization antibodies onto the surface of nanoparticles.
Supervisor(s)
Research Location
Program Type
Masters/PHD
Synopsis
Curcumin, a polyphenol extract from plant and the active compound of the Indian spice turmeric, has a broad spectrum of pharmacological activities, including anti-microbial, anti-oxidant, anti-inflammatory and anti-cancer. However, its low water-solubility, therefore inadequate bioavailability, remains a major hurdle that limits its medical applications. My team is developing and characterizing mono-dispersed and non-aggregated curcumin nano-particles to increase curcumin's bioavailability and to promote its anti-cancer and anti-microbial effects. The results demonstrate that in a size-depending manner, nano-formulation of curcumin increases its skin penetration as well as its uptake rate into different cancer cell lines.
Additional Information
This is a joint project between Faculty of Pharmacy and Department of Physiology, University of Sydney) and School of Pharmacy, University of Technology, Sydney.
Want to find out more?
Contact us to find out what’s involved in applying for a PhD. Domestic students and International students
Contact Research Expert to find out more about participating in this opportunity.
Browse for other opportunities within the Sydney Pharmacy School .
Keywords
Curcumin nanoparticles, Anti-cancer and Anti-microbial Nanoparticles, Liposome, Biomaterials, tissue engineering
Opportunity ID
The opportunity ID for this research opportunity is: 1720
Other opportunities with Dr Ramin Rohanizadeh